Analyze Diet

Topic:Vaccine

Vaccination in horses involves the administration of biological preparations designed to stimulate the equine immune system to recognize and combat specific pathogens. Vaccines are formulated to prevent or reduce the severity of infectious diseases that can affect equine health and performance. Common vaccines for horses include those for equine influenza, tetanus, equine herpesvirus, and West Nile virus. The administration schedule and type of vaccine can vary based on factors such as geographic location, age, and use of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in horses, as well as their impact on equine health management.
Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses.
Veterinary immunology and immunopathology    February 27, 1998   Volume 59, Issue 3-4 239-251 doi: 10.1016/s0165-2427(97)00074-3
Sheoran AS, Sponseller BT, Holmes MA, Timoney JF.Equine strangles, caused by the clonal pathogen Streptococcus equi, is a source of serious economic loss despite the widespread use of commercial vaccines. The anti-phagocytic 58 kDa M-like protein (SeM) is an important protective antigen. The objective of this study was to define differences, if any, between SeM-specific convalescent serum and mucosal IgA and IgG subisotypes and those induced by vaccination with commercial strangles vaccine. SeM-specific opsonophagocytic IgGb was the predominant serum antibody in horses intramuscularly vaccinated or recently recovered from infection. Infectio...
An outbreak of foal yersiniosis in Poland: pathological and bacteriological examination.
Zentralblatt fur Bakteriologie : international journal of medical microbiology    January 24, 1998   Volume 286, Issue 4 542-546 doi: 10.1016/s0934-8840(97)80058-8
Czernomysy-Furowicz D.In the springtime of 1995, 10 per cent of foals at a stud-farm died due to suppurative lesions. Three dead foals were examined. The manifestations of watery diarrhoea and pneumonia were observed. A profuse growth of an enterotoxigenic strain of Yersinia pseudotuberculosis was obtained from the internal organs of the foals. The foals with clinical symptoms of pneumonia and watery diarrhoea were immunized with Propionibacterium acnes t. II. All mares and their offspring from the stud were treated with an immunomodulator (Propionibacterium acnes t. II) and then vaccinated with a formalin-inactiva...
Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice.
Vaccine    July 1, 1997   Volume 15, Issue 10 1149-1156 doi: 10.1016/s0264-410x(96)00309-x
Olsen CW, McGregor MW, Dybdahl-Sissoko N, Schram BR, Nelson KM, Lunn DP, Macklin MD, Swain WF, Hinshaw VS.Two fundamentally different approaches to vaccination of BALB/c mice with the hemagglutinin (HA) of A/Equine/Kentucky/1/81 (H3N8) (Eq/KY) were evaluated, that is, administration of HA protein vs administration of HA-encoding DNA. Each vaccine was tested for its immunogenicity and ability to provide protection from homologous virus challenge. HA protein was synthesized in vitro by infection of Sf21 insect cells with a recombinant baculovirus. Intranasal administration of this vaccine induced virus-specific antibodies, as measured by enzyme-linked immunosorbent assay (ELISA), but did not induce ...
Immunoprophylaxis of Rhodococcus equi pneumonia in foals.
Veterinary microbiology    June 16, 1997   Volume 56, Issue 3-4 193-204 doi: 10.1016/s0378-1135(97)00088-6
Becú T, Polledo G, Gaskin JM.An immunoprophylaxis program for R. equi infection of foals has been established on a number of thoroughbred breeding farms in Argentina over the past 4 years. Nearly 800 mares annually were immunized subcutaneously during the last 2 months of pregnancy with 2-3 doses of a vaccine containing soluble antigens of R. equi, including the virulence associated protein (VapA) and 'equi factors' exoenzymes. The mortality from R. equi pneumonia in the foals from vaccinated dams dropped from an average of 3% in the 5 years before the vaccination program was initiated to an average of 1.2% in the 4 years...
Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines.
Veterinary microbiology    June 16, 1997   Volume 56, Issue 3-4 205-212 doi: 10.1016/s0378-1135(97)00089-8
Varga J, Fodor L, Rusvai M, Soós I, Makrai L.Two different, inactivated, aluminium salt adsorbed vaccines, one containing a R. equi strain (serotype 1, 10(9) CFU/ml and equine herpesvirus 2 (EHV-2) (1.5 x 10(7) PFU/ml) and another containing R. equi only were used on three studfarms to determine whether the disease can be prevented by vaccination of both pregnant mares and their foals. Pregnant mares received two 3 ml doses of vaccine intramuscularly 6 and 2 weeks before parturition and their foals were vaccinated on two or three occasions at 3, 5 or 7 weeks of age. The efficacy of the vaccines was evaluated on the basis of the clinical ...
Botulism.
The Veterinary clinics of North America. Equine practice    April 1, 1997   Volume 13, Issue 1 107-128 doi: 10.1016/s0749-0739(17)30259-6
Whitlock RH, Buckley C.Equine botulism is being recognized with increasing frequency by veterinarians throughout North America. Muscular weakness and dysphagia that progress during a period of 1 to 4 days, in the absence of laboratory derangements that indicate the presence of systemic disease, are suggestive of botulism. A tentative diagnosis usually is based on the presence of the following findings on physical examination: delayed pupillary light response, mydriasis, ptosis, generalized weakness, decreased tail tone, and slow prehension of feed. Definitive diagnosis requires detection of botulinum toxin in plasma...
Simulation studies of vaccination strategies in African horse sickness.
Vaccine    April 1, 1997   Volume 15, Issue 5 519-524 doi: 10.1016/s0264-410x(97)00220-x
Lord CC, Woolhouse ME, Mellor PS.A simulation model including two hosts (horses and donkeys) and one vector (Culicoides imicola) for African horse sickness in Spain is extended to consider vaccination strategies. If hosts were protected prior to virus introduction, elimination of simulated epidemics was related nonlinearly to the fraction protected. Protecting donkeys as well as horses increased the effectiveness of vaccination. Prevention of 50% of epidemics required 75% coverage of horses and donkeys or 90% coverage of horses only. Protection after the introduction of the virus was rarely successful in preventing outbreaks....
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995.
The Journal of infectious diseases    April 1, 1997   Volume 175, Issue 4 828-832 doi: 10.1086/513978
Rivas F, Diaz LA, Cardenas VM, Daza E, Bruzon L, Alcala A, De la Hoz O, Caceres FM, Aristizabal G, Martinez JW, Revelo D, De la Hoz F, Boshell J....In 1995, the first Venezuelan equine encephalitis (VEE) outbreak in Colombia in 22 years caused an estimated 75,000 human cases, 3000 with neurologic complications and 300 fatal, in La Guajira State. Of the state's estimated 50,000 equines, 8% may have died. An epizootic IC virus, probably introduced from Venezuela, was rapidly amplified among unvaccinated equines. Record high rainfall, producing high densities of vector Aedes taeniorhynchus, led to extensive epidemic transmission (30% attack rate) in the four affected municipalities. Native Wayuu Indians, constituting 24% of the state's popul...
[An epizootiologic study of an outbreak of equine influenza in the Czech Republic in the fall of 1995].
Veterinarni medicina    February 1, 1997   Volume 42, Issue 2 39-42 
Lány P, Pospísil Z, Zendulková D, Cíhal P, Jahn P.A mild outbreak of acute respiratory infection was reported in racing horses in the fall of 1995. Four studs were investigated for the sources and routes of infection. In five horses from two herds, virus isolates were obtained which, in preliminary typing experiments, were identified as the influenza A/equi 2 virus. The presence of this illness in all the examined herds was confirmed by a rise in specific antibody titres. The affected animals included both older vaccinated horses and young horses not yet vaccinated. Epidemiological studies suggested that the spread of infection occurred in si...
Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
The Journal of general virology    September 1, 1996   Volume 77 ( Pt 9) 2053-2057 doi: 10.1099/0022-1317-77-9-2053
Roy P, Bishop DH, Howard S, Aitchison H, Erasmus B.African horsesickness virus serotype 4 (AHSV-4) outer-capsid proteins VP2 or VP2 and VP5, prepared from single or dual recombinant baculovirus expression vectors grown in Sf9 insect cells, were administered in different amounts to horses and the neutralizing antibody responses were measured. Control and vaccinated horses were challenged with virulent AHSV-4 6 months later and monitored post challenge. The results indicated that two inoculations of extracts containing VP2 and VP5, or VP2 alone, in doses of 5 micrograms VP2 or more per horse, were sufficient to elicit protection against African ...
Clinical presentation of experimentally induced rabies in horses.
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    July 1, 1996   Volume 43, Issue 5 277-285 doi: 10.1111/j.1439-0450.1996.tb00315.x
Hudson LC, Weinstock D, Jordan T, Bold-Fletcher NO.Twelve naive and nine test-vaccinated horses which developed clinical signs of rabies as a result of the required protocol of a vaccine trial were prospectively observed. Nineteen of the 21 cases were confirmed positive for rabies infection of the brain by fluorescent antibody test. The two horses with negative results had ganglioneuritis of the trigeminal ganglion or lymphocytic perivascular cuffing in the brain stem in addition to clinical signs. Average incubation period was 12.3 days and average morbidity was 5.5 days. Naive animals had significantly shorter incubation and morbidity period...
Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
Virology    June 1, 1996   Volume 220, Issue 1 219-222 doi: 10.1006/viro.1996.0304
Stone-Marschat MA, Moss SR, Burrage TG, Barber ML, Roy P, Laegreid WW.Horses were immunized by inoculation with a vaccinia construct containing a full-length cDNA corresponding to the L2 gene segment of African horsesickness virus type 4(AHSV-4). All immunized horses developed serum neutralizing antibodies prior to challenge with virulent AHSV-4. No ELISA-reactive antibodies were present prior to challenge. A group of four seronegative control horses died after developing clinical signs and lesions typical of the pulmonary form of African horsesickness while the immunized horses were clinically normal. Increases in serum neutralizing and ELISA-reactive antibody ...
Equine influenza.
Comparative immunology, microbiology and infectious diseases    June 1, 1996   Volume 19, Issue 3 205-211 doi: 10.1016/0147-9571(96)00006-9
Timoney PJ.A highly contagious virus infection of horses, influenza is the single most important equine respiratory disease in many countries. Two subtypes of equine influenza virus have been identified, A/equine-1 and A/equine-2, neither of which immunologically cross-reacts. In the case of A/equine-2 virus, two lineages exist, American and European, which appear to have evolved independently of one another. The acute febrile respiratory disease characteristic of influenza is frequently complicated by secondary bacterial infection, especially in unvaccinated horses. Primarily a respiratory-borne infecti...
Remotely delivered immunocontraception in free-roaming feral burros (Equus asinus).
Journal of reproduction and fertility    May 1, 1996   Volume 107, Issue 1 31-35 doi: 10.1530/jrf.0.1070031
Turner JW, Liu IK, Kirkpatrick JF.Regulation of local overpopulations of free-roaming feral equids is in demand worldwide for ecological balance and habitat preservation. Contraceptive vaccines have proven effective in feral horses, which breed seasonally, but no data are available for equids such as the burro, which is reproductively active all year round. In the present study, 27 individually identified female feral burros (Equus asinus) roaming free in Virgin Islands National Park (St John, US Virgin Islands; Lesser Antilles) were remotely treated with pig zonae pellucidae (PZP) vaccine. Between January and May, 16 burros w...
Effect of vaccination of ponies with A4 anti-idiotypic antibody on serum idiotype (1C9) and antilipid A concentration.
American journal of veterinary research    May 1, 1996   Volume 57, Issue 5 655-658 
BonenClark GD, MacKay RJ, Ward RE, Sheerin B.To evaluate the humoral response of horses to vaccination, using a murine monoclonal anti-idiotypic antibody (A4) that shares an epitope with lipid A. Methods: Serum concentrations of antilipid A antibody and 1C9 (epitope on murine monoclonal antilipid A antibody) were measured serially during the period of vaccination with A4. Methods: 6 clinically normal adult ponies. Methods: Ponies were inoculated IM 3 times at monthly intervals with A4. Two weeks after each inoculation, serum was obtained and was assayed by ELISA for antilipid A and 1C9 concentrations. Additional vaccinations were given t...
Benefit-cost analysis of vaccination of horses as a strategy to control equine monocytic ehrlichiosis.
Journal of the American Veterinary Medical Association    April 15, 1996   Volume 208, Issue 8 1295-1299 
Atwill ER, Mohammed HO.To determine whether horses in New York should be vaccinated against equine monocytic ehrlichiosis (EME). Methods: Decision-tree analyses of data from a cross-sectional study and a case-control study. Methods: Horses in New York. Methods: Annual expected monetary loss per horse attributable to EME was calculated for vaccinated and nonvaccinated horses in New York. Because risk of being seropositive was dependent on county in which the horse was located, farm elevation, and use of each horse, decision-tree analyses were stratified by these factors. Results: Annual expected monetary loss per hor...
Antigenic and genetic evolution of equine H3N8 influenza A viruses.
The Journal of general virology    April 1, 1996   Volume 77 ( Pt 4) 661-671 doi: 10.1099/0022-1317-77-4-661
Daly JM, Lai AC, Binns MM, Chambers TM, Barrandeguy M, Mumford JA.Evolution of equine influenza a H3N8 viruses was examined by antigenic and genetic analysis of a collection isolates from around the world. It was noted that antigenic and genetic variants of equine H3N8 viruses cocirculate, and in particular that variants currently circulating in Europe and the USA are distinguishable from one another both in terms of antigenic reactivity and genetic structure of the HA1 portion of the haemagglutinin (HA) molecule. Whilst the divergent evolution of American and European isolates may be due to geographical isolation of the two gene pools, some mixing is believ...
Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines.
AIDS research and human retroviruses    March 20, 1996   Volume 12, Issue 5 413-415 doi: 10.1089/aid.1996.12.413
Montelaro RC, Grund C, Raabe M, Woodson B, Cook RF, Cook S, Issel CJ.No abstract available
Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
The Journal of general virology    March 1, 1996   Volume 77 ( Pt 3) 435-442 doi: 10.1099/0022-1317-77-3-435
Grund CH, Lechman ER, Pezzuolo NA, Issel CJ, Montelaro RC.Equine infectious anaemia virus (EIAV) provides a model for examining the natural immunological control of a persistent lentivirus infection and for evaluating the efficacy of various vaccine strategies. As an initial characterization of antibody responses associated with protective or enhancing immune responses elicited by experimental infections or vaccinations, we have utilized synthetic peptide ELISA to characterize the fine specificity of antibodies to linear determinants of the EIAV surface glycoprotein, gp90. The data indicated that serum antibodies associated with protective or enhanci...
Applications of pig zona pellucida immunocontraception to wildlife fertility control.
Journal of reproduction and fertility. Supplement    January 1, 1996   Volume 50 183-189 
Kirkpatrick JF, Turner JW, Liu IK, Fayrer-Hosken R.A unique application of pig zona pellucida (PZP) immunocontraception is the control of wildlife populations. A native PZP vaccine has been successfully applied to wild horse and donkey populations. A single annual booster inoculation was capable of maintaining contraception. Seven consecutive years of PZP treatment in wild mares resulted in no detectable debilitating side effects, and reversibility of contraception has been documented among mares treated for up to 4 consecutive years. Long-term treatment (5-7 years) is associated with some ovulation failure and depressed urinary oestrogen conc...
[Jenner’s cowpox vaccine in light of current vaccinology].
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie    January 1, 1996   Volume 58, Issue 5 479-538 
Huygelen C.Two hundred years ago Edward Jenner inoculated James Phipps with vaccinia and 181 years later smallpox had disappeared from the surface of the earth as a result of generalized vaccination. Compared to the requirements of modern vaccinology, the procedures used by Jenner and his successors, were extremely primitive because of an almost total lack of knowledge in the field of microbiology and immunology. The active principle of smallpox vaccine is vaccinia virus, which in many respects, differs from that of natural cowpox; the term "cowpox" has been used for more than a century and a half to des...
Reactions to strangles vaccination.
Australian veterinary journal    December 1, 1995   Volume 72, Issue 12 480 doi: 10.1111/j.1751-0813.1995.tb03502.x
Sezun GS.No abstract available
Equine influenza in vaccinated horses.
The Veterinary record    November 4, 1995   Volume 137, Issue 19 495-496 doi: 10.1136/vr.137.19.495
Newton JR, Mumford JA.No abstract available
Guidelines for vaccination of horses. The American Association of Equine Practitioners’ Vaccination Guidelines Subcommittee of the AVMA Council on Biologic and Therapeutic Agents.
Journal of the American Veterinary Medical Association    August 15, 1995   Volume 207, Issue 4 426-431 
No abstract available
Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL.
The Journal of general virology    August 1, 1995   Volume 76 ( Pt 8) 1989-1998 doi: 10.1099/0022-1317-76-8-1989
Chirnside ED, de Vries AA, Mumford JA, Rottier PJ.Complementary DNAs encoding ORFs 2 to 7 equine arteritis virus (EAV) have been cloned into the expression vector pGEX to produce glutathione-S-transferase fusion proteins. Recombinant proteins were affinity purified and screened in ELISA with equine sera to identify immunoreactive polypeptides. The large envelope glycoprotein (GL) was identified as the most reactive to EAV-positive equine sera and an immuno-dominant epitope was mapped between amino acids 55 and 98 by subcloning and expression. A fusion protein covering this region and a GL-specific synthetic peptide (residues 75 through 97) in...
Outbreak of equine influenza among horses in Hong Kong during 1992.
The Veterinary record    May 27, 1995   Volume 136, Issue 21 531-536 doi: 10.1136/vr.136.21.531
Powell DG, Watkins KL, Li PH, Shortridge KF.Equine-2 influenza virus A (H3N8) infection occurred among vaccinated thoroughbred horses in Hong Kong during November and December 1992. The outbreak was unique in that it occurred among a large population stabled under intensive conditions. It resulted in the postponement of seven race meetings over a period of 32 days. The outbreak originated after the importation of horses 25 to 32 days before any clinical signs were reported. Vaccination did not prevent 75 per cent of the population from becoming infected, and half the infected horses developed clinical signs. Vaccination did, however, co...
Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
Journal of the American Veterinary Medical Association    March 15, 1995   Volume 206, Issue 6 823-832 
Ellis JA, Bogdan JR, Kanara EW, Morley PS, Haines DM.The ability of monovalent and bivalent equine herpesvirus (EHV) vaccines to stimulate cellular and antibody responses to EHV-1 and EHV-4 was compared in healthy horses. Comparison of data from lymphocyte blastogenesis tests in which live viruses were used as antigens and that were conducted prior to vaccination and after 2 vaccinations revealed that horses given modified-live EHV-1 had significant increases in proliferative responses to EHV-1 (P = 0.03) and EHV-4 (P = 0.04). Responses to EHV-1 and EHV-4 in horses given the inactivated-virus bivalent vaccine were less; however, significant diff...
Response of ponies to adjuvanted EHV-1 whole virus vaccine and challenge with virus of the homologous strain.
The British veterinary journal    January 1, 1995   Volume 151, Issue 1 27-37 doi: 10.1016/s0007-1935(05)80061-2
Dolby CA, Hannant D, Mumford JA.Five yearling ponies were vaccinated with inactivated Equid herpesvirus type 1 (EHV-1) in Freund's complete adjuvant as a double emulsion and revaccinated 6 weeks later with EHV-1 in Freund's incomplete adjuvant. These ponies and three age-matched controls were challenged intra-nasally after a further 6 weeks with homologous live virus and monitored clinically, biologically and serologically. After challenge, clinical signs were mild in both groups. No cell-associated viraemias were detected in vaccinated ponies. Vaccination induced high levels of complement-fixing (CF) and virus-neutralizing ...
Reactions to strangles vaccination.
Australian veterinary journal    August 1, 1994   Volume 71, Issue 8 257-258 doi: 10.1111/j.1751-0813.1994.tb03423.x
Smith H.No abstract available
Horse products for tetanus prophylaxis. Shindman J.No abstract available
1 19 20 21 22 23 29